This position is for an Outpatient Oncology Clinical Pharmacy Specialist that would practice at a brand new offisite Oncology Clinic, that includes a newly built USP 800 compliant infusion center pharmacy supported by operational pharmacists and technicians. The Oncology Clinical Pharmacy Specialist would have the following responsibilities:
1. ‘Clean Chemo’ review - to review the entire treatment plan for each patient receiving treatment in the infusion center 24-72 hours in advance of their scheduled appointment. This process referred to as a “Clean Chemo” review would ensure that the chemotherapy template chosen is correct, medications are ordered appropriately based on patient specifics and current guidelines, parameters for medication administration are clear, concise and consistent, lab work is appropriately scheduled, administration instructions are clear, and pre/post-chemo medications are correctly ordered and scheduled. This process ensures that when the patient arrives orders can be verified and processed through the pharmacy in an efficient and safe manner, without the need for significant revisions.
2. Patient education – all patients would receive pharmacist education in advance of their first treatment regardless of whether they are receiving IV or oral chemotherapy regimens, including specialty medications. A pharmacist would educate each patient on their prescribed regimen, including the purpose and side effects of the medication, in alignment with patient HCAHPS and regulatory required education. Pharmacist driven patient education would continue via follow-up calls or visits, ensuring the patient remains fully aware of the status of their treatment plan, labs, side effects, and potential changes in therapy throughout their entire course of treatment. For Specialty medications, this education would be coupled with the required creation of clinical assessments and subsequent documentation of the patient education in both Therigy and EPIC, ensuring our documentation is consistent with URAC accreditation requirements.
3. Template review – each pharmacist would be responsible for the clinical review of any newly requested treatment or supportive care plans for use at any of our oncology infusion centers. Pharmacists would field such requests from the oncologists and nurses they work with, but would also be responsible for the regular review and revision of the protocols used by their group of oncologists. This review would include constant analysis of the current national guidelines (NCCN) to ensure each treatment plan was not only current, but also referenced and named appropriately. Upon pharmacy approval, the pharmacists would submit the necessary template build information to BEACON/WILLOW and would review the accuracy of the build along with the Oncology Protocol Review Committee before moving the changes to BEACON/EPIC production.
4. Investigational Drug Study review – each pharmacist would be responsible for the clinical review of any oncology related investigational drug study prior to approval for use. Pharmacists would work hand in hand with the lead oncologists and study coordinators to determine feasibility and operational/clinical design needs in order to ensure the successful implementation of each study. They would also be responsible for the education of any involved pharmacy staff in addition to the creation of a pharmacy specific study binder designed to include all of the study details, and required documentation.
5. Physician & Nursing Education – each pharmacist would be expected to provide physician and nursing education. This would include education on new medications, changes to standard treatment plans, financial implication of treatment selection, monitoring related to medication use, etc. Informal education sessions as well as formal education sessions such as in-services, clinical pearls, continuing education opportunities, etc. will be provided on a regular basis.
PGY-1 and PGY-2 Oncology Residency completion preferred
About New Hanover Regional Medical Center
New Hanover Regional Medical Center (NHRMC) is an 855 bed, certified stroke and level II trauma center, with its primary service area including the seven-county region of Southeastern North Carolina. As a community teaching hospital, NHRMC houses 4 pharmacy residency programs (PGY1 Community-Based, PGY1 Pharmacy, PGY2 Ambulatory Care, PGY2 Critical Care), in addition to 4 medical residency programs (Family Medicine, Internal Medicine, Obstetrics/Gynecology, and Surgery). NHRMC is home to the Wilmington campus of the UNC School of Medicine and is affiliated with several pharmacy programs, including Campbell, High Point, and Wingate Universities. The health system includes the NHRMC main campus, a free-standing Emergency Department, an orthopedic hospital, and numerous outpatient clinics. The main campus includes a 108 bed Emergency Department, women’s and children’s hospital, a behavioral health hospital, an inpatient rehabilitation hospital, and an ambulatory oncology center. The most common disease states encountered include sepsis, pneumonia, heart disease, cerebrovascular disease, chronic respiratory disease, and trauma.
In accordance with our mission statement, NHRMC measu...res our success by the health of our community and has made it our mission to improve all aspects of health in our service area. We are focused on delivering access to value based care and health equity to the community we serve. Our organization is striving to reach beyond the walls of our hospitals to ensure members of our community experience outstanding health in the most convenient, affordable way that is customized to their unique circumstances.
Wilmington is a growing coastal community of over 100,000 people in Southeastern North Carolina. Enjoy living and working where most people vacation. Year-round boating, golf, fishing, tennis, and biking are available. We have a vibrant, historical downtown with excellent restaurants and an active cultural arts community.
For more information, visit us at nhrmc.org